Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Propel Bio Management, LLC
Form 13F · Q2 2026

Propel Bio Management, LLC

CIK 1969764申报日 2026-08-1313F-HR 在 EDGAR 查看原始申报 ↗
$1.9亿
申报组合市值
29
持仓数量
11
Quarters on record
Top 50
持仓数量

Propel Bio Management, LLC——持仓

共 29 个持仓中的前 29 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1PAGP Plains Gp Hldgs L P1.3M+0.0%$3088万16.2%
2QUIT Achieve Life Science Inc4.0M+6.5%$2634万13.8%
3CORT Corcept Therapeutics Inc136,499−7.7%$1187万6.2%
4PHAT Phathom Pharmaceuticals Inc1.1M+24.9%$1140万6.0%
5DCTH Delcath Sys Inc871,460−11.0%$1097万5.7%
6MIST Milestone Pharmaceuticals In7.4M+80.4%$996万5.2%
7CMPS Compass Pathways Plc573,086−22.8%$811万4.2%
8KYTX Kyverna Therapeutics Inc883,198+37.1%$787万4.1%
9ARTV Artiva Biotherapeutics Inc696,436+375.8%$676万3.5%
10ABEO Abeona Therapeutics Inc983,070−26.1%$608万3.2%
11AQST Aquestive Therapeutics Inc1.4M+102.9%$600万3.1%
12PALI Palisade Bio Inc2.6M+131.6%$540万2.8%
13IMUX Immunic Inc325,022—$500万2.6%
14IVA Inventiva Sa1.3M+76.8%$484万2.5%
15SABS Sab Biotherapeutics Inc1.1M+6.3%$420万2.2%
16OBIO Orchestra Biomed Hldgs Inc896,701+0.0%$387万2.0%
17CLDX Celldex Therapeutics Inc New103,695−21.1%$386万2.0%
18ZVRA Zevra Therapeutics Inc253,544−10.2%$364万1.9%
19OCUL Ocular Therapeutix Inc357,966−6.4%$352万1.8%
20FDMT 4D Molecular Therapeutics In252,654−33.6%$336万1.8%
21OVID Ovid Therapeutics Inc1.1M+21.1%$300万1.6%
22EYPT Eyepoint Inc191,745−11.2%$274万1.4%
23UPB Upstream Bio Inc350,389+2.5%$242万1.3%
24SCYX Scynexis Inc543,478—$221万1.2%
25SLN Silence Therapeutics Plc191,733—$211万1.1%
26LONA Leonabio Inc149,279+0.0%$137万0.7%
27MAZE Maze Therapeutics Inc43,798+0.0%$131万0.7%
28CRVS Corvus Pharmaceuticals Inc70,380−18.0%$105万0.6%
29SGMT Sagimet Biosciences Inc125,878—$97万0.5%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。